Stock research
GNPX Genprex, Inc.
Healthcare • Biotechnology
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients...…
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
5Y change
-100.00%
Range high
$154,000.00
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in GNPX?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $6.06
- Day High
- $6.26
- Day Low
- $5.56
- 52w High
- $1,210.00
- 52w Low
- $5.51
- Volume
- 26,866.73691
- Avg Volume
- Beta
- -0.911
* TTM/most recent where available
Company
- Ticker
- GNPX
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Ryan Confer
- Employees
- 13
- Website
- www.genprex.com
Key Metrics
- Market Cap
- 2.86M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).